Background: The incidence of remissions in pemphigus is unclear because the
se are usually reported at a single point in the evolution of the disease.
Thus it is uncertain whether treatment simply suppresses the manifestations
of the disease and consequently must be continuously administered, or indu
ces complete and long-lasting remissions that permit therapy to be disconti
nued.
Objective: To answer this question, we investigated the incidence of remiss
ion in a long-term longitudinal study
Methods: The induction of complete and long-lasting remissions (lesion free
with no systemic therapy for at least 6 months) was studied in 40 patients
with pemphigus vulgaris treated conventionally and followed up for an aver
age of 7.7 years by the same investigator.
Results: Five (5%) of the patients died of the disease. Complete and long-l
asting remissions were induced in 25%, 50%, and 75% of patients 2, 5, and 1
0 years, respectively, after diagnosis. Most of the remaining patients were
in partial remission or had mild disease controlled with a small dose of s
teroids. The course of the disease followed different patterns, with some p
atients rapidly entering complete and long-lasting remissions, whereas othe
rs never entered into a complete remission. The induction of complete remis
sion was related to the initial severity and extent of disease and to ear l
y response to treatment.
Conclusion: It is possible to eventually induce complete and durable remiss
ions in most patients with pemphigus that permit systemic therapy to be saf
ely discontinued without a flare in disease activity. The proportion of pat
ients in whom this can be achieved increases steadily with time, and therap
y can be discontinued in approximately 75% of patients after 10 years.